Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK), founded in 1884, is the world's oldest and largest private institution dedicated to conquering cancer. It unites physicians, scientists, nurses, and staff in a relentless pursuit of advanced cancer research and exceptional patient care. Consistently ranked among the top cancer hospitals nationwide and number one in the Northeast, MSK leverages its extensive research and clinical leadership to deliver highly individualized treatments. Its core mission focuses on discovery, prevention, and developing novel therapies for all forms of cancer.

Operating across 40 locations, MSK employs over 10,000 dedicated professionals committed to patient well-being and scientific advancement. The institution fosters a collaborative environment where cutting-edge research directly informs patient treatment protocols, ensuring the highest standard of care. This collective expertise and unwavering dedication are central to MSK's success in advancing oncology. Meet Memorial Sloan Kettering Cancer Center's team to understand the breadth of talent driving its mission.

MSK's comprehensive offerings include advanced cancer treatment, pioneering research, and robust patient support programs. The center leads in drug development and scientific discovery, translating laboratory breakthroughs into tangible patient benefits. In a competitive landscape with institutions like The University of Texas MD Anderson Cancer Center and Dana-Farber Cancer Institute, MSK distinguishes itself through its specialized focus and integrated approach to cancer care. Its annual revenue of $7.4B underscores its significant operational scale and impact in the global fight against cancer.